Cascade Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-300
| Closed | -$20.8K | – | 121 |
|
|
2023
Q1 | $20.8K | Buy |
+300
| New | +$20.8K | 0.02% | 184 |
|
|
2022
Q3 | – | Sell |
-22,715
| Closed | -$1.75M | – | 116 |
|
|
2022
Q2 | $1.75M | Sell |
22,715
-4,782
| -17% | -$368K | 1.37% | 7 |
|
|
2022
Q1 | $2.01M | Sell |
27,497
-503
| -2% | -$36.7K | 1.22% | 14 |
|
|
2021
Q4 | $1.75M | Buy |
28,000
+665
| +2% | +$41.5K | 1.02% | 30 |
|
|
2021
Q3 | $1.62M | Buy |
27,335
+505
| +2% | +$29.9K | 1.05% | 32 |
|
|
2021
Q2 | $1.79M | Sell |
26,830
-25
| -0.1% | -$1.67K | 1.13% | 23 |
|
|
2021
Q1 | $1.7M | Buy |
26,855
+1,370
| +5% | +$86.5K | 1.1% | 26 |
|
|
2020
Q4 | $1.58M | Sell |
25,485
-10
| -0% | -$620 | 1.16% | 19 |
|
|
2020
Q3 | $1.54M | Buy |
25,495
+25
| +0.1% | +$1.51K | 1.3% | 16 |
|
|
2020
Q2 | $1.5M | Sell |
25,470
-765
| -3% | -$45K | 1.41% | 10 |
|
|
2020
Q1 | $1.46M | Buy |
26,235
+25
| +0.1% | +$1.39K | 1.61% | 9 |
|
|
2019
Q4 | $1.68M | Sell |
26,210
-1,245
| -5% | -$79.9K | 1.29% | 14 |
|
|
2019
Q3 | $1.39M | Buy |
27,455
+955
| +4% | +$48.4K | 1.07% | 29 |
|
|
2019
Q2 | $1.2M | Buy |
26,500
+4,015
| +18% | +$182K | 1.02% | 40 |
|
|
2019
Q1 | $1.07M | Buy |
22,485
+6,850
| +44% | +$327K | 0.96% | 47 |
|
|
2018
Q4 | $813K | Buy |
15,635
+14,635
| +1,464% | +$761K | 0.82% | 59 |
|
|
2018
Q3 | $62.1K | Hold |
1,000
| – | – | 0.05% | 124 |
|
|
2018
Q2 | $55.3K | Buy |
+1,000
| New | +$55.3K | 0.05% | 123 |
|
|
2016
Q2 | $22.1K | Buy |
+300
| New | +$22.1K | 0.02% | 123 |
|